Xeris Biopharma Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Xeris Biopharma Holdings Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- XERS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001867096
Board of directors
-
Barbara-Jean Anne Bormann-Kennedy · DirectorSince 2023
-
Dawn Halkuff · DirectorSince 2023
-
Garheng Kong · DirectorSince 2023
-
James Aloysius Brady · DirectorSince 2025
-
Jeffrey W. Sherman · DirectorSince 2023
-
John Johnson · DirectorSince 2023
-
John P. Schmid · DirectorSince 2023
-
John Patrick Shannon Jr. · Director · See RemarksSince 2024
-
Marla Persky · DirectorSince 2023
-
Paul R. Edick · Director · See RemarksSince 2023
-
Ricki Louise Fairley · DirectorSince 2023
Board connections
6 of this board's directors also sit on 9 other boards.
- via John P. Schmid
- via John Johnson
- via Barbara-Jean Anne Bormann-Kennedy
- via John P. Schmid
- via John P. Schmid
- via Garheng Kong
- via Jeffrey W. Sherman
- via John Johnson
- via Paul R. Edick
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,497,495
- 5 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | John Johnson Director | Open-market sale | −135,400 | $7.22 | $977,588 |
| Dec 12, 2025 | Barbara-Jean Anne Bormann-Kennedy Director | Open-market sale | −15,000 | $7.09 | $106,350 |
| Dec 1, 2025 | Hecht Beth Officer (See Remarks) | Open-market sale | −16,667 | $7.01 | $116,836 |
| Nov 14, 2025 | John Patrick Shannon Jr. Director, Officer (See Remarks) | Option exercise | +87,100 | $1.55 | $135,005 |
| Nov 13, 2025 | John Patrick Shannon Jr. Director, Officer (See Remarks) | Option exercise | +8,970 | $1.55 | $13,904 |
| Nov 13, 2025 | John Patrick Shannon Jr. Director, Officer (See Remarks) | Open-market sale | −23,242 | $7.46 | $173,385 |
| Nov 11, 2025 | Hecht Beth Officer (See Remarks) | Open-market sale | −16,667 | $7.40 | $123,336 |
| Oct 2, 2025 | McCulloch Kevin Officer (See Remarks) | Shares withheld for tax | −733 | $8.31 | $6,091 |
| Sep 11, 2025 | McCulloch Kevin Officer (See Remarks) | Other | −2,000 | — | — |
| Sep 11, 2025 | Marla Persky Director | Open-market sale | −15,500 | $7.72 | $119,660 |
| Aug 28, 2025 | Jeffrey W. Sherman Director | Option exercise | +47,040 | $6.66 | $313,286 |
| Aug 28, 2025 | Jeffrey W. Sherman Director | Open-market sale | −42,232 | $7.92 | $334,477 |
| Aug 13, 2025 | John Johnson Director | Open-market sale | −107,500 | $7.32 | $786,900 |
| Aug 12, 2025 | Dawn Halkuff Director | Open-market sale | −42,500 | $7.28 | $309,400 |
| Aug 1, 2025 | John Patrick Shannon Jr. Director, Officer (See Remarks) | Shares withheld for tax | −36,918 | $5.38 | $198,619 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.